Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Cancer has always been one of the most threatening diseases in the world with a high chance of mortality. According to WHO, the global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. There are several factors that are attributed to the several factors, including population growth and ageing as well as the changing prevalence of certain causes of cancer linked to social and economic development. Oncology nutrition is an integral part of the cancer recovery process as a whole. It plays an important role in improving bodily resources, tolerance of cancer treatments, and the overall quality of life.
Increasing cases of cancer disease and increasing requirement to meet the nutritional demands during treatment are the major key factors, driving the growth of the market.For instance, According to WHO, every sixth death in the globe is because of cancer, which makes it the second most common cause of death. In 2017, 9.6 million people are projected to have died from the different forms of cancer. In addition, increasing awareness programs in developing countries regarding benefits of nutritional requirements are also boosting the market.
The report analyses the global Oncology Nutrition market based Nutrition Support, Type of Cancer and Geography.
The oncology nutrition can be supported through enteral and parenteral nutrition. Enteral nutrition is preferred for patients with a functioning gastrointestinal tract because it is more physiological, entails fewer complications and is comparatively less expensive than parenteral nutrition. Moreover, the enteral administration supports lowers the risk of infection and contamination. Maintaining small intestine mass and pancreatic functions, improves healing & recovery. Thus, the successful enteral nutrition therapy has limited the use of parenteral nutrition therapy, resulting in important benefit in terms of safety, manageability, and cost.
Oncology Nutrition market finds application in Head & Neck Cancer, Gastrointestinal Cancers, Esophageal Cancer, Pancreatic Cancer, Liver Cancer and Blood Cancer etc. Patients with head and neck cancer face unique challenges in maintaining adequate nutrition. Both the disease itself and the treatments, especially surgery and radiation therapy, have significant negative impact on upper digestive tract function and oral intake is often insufficient during and after therapy. Thus, there is large demand of the oncology nutrition in the treatment of head and neck cancer.
The Oncology Nutrition market is studied for the key regions including North America, Europe, Asia Pacific and Rest of the World. The North America region dominated the global oncology nutrition market. The large share of North America can be attributed to the high adoption of oncology nutrition among the aging population, increasing prevalence of cancer, the presence of many large hospitals. The presence of a large number of global players in this region is another key factor contributing to the large share of this market segment
Key players in the global Oncology Nutrition market include Eurofins Scientific, Charles River Laboratories International, Becton, Dickinson and Company, SGS, Merck KGaA, bioMérieux , Pacific Biolabs , WuXi AppTec , North American Science Associates, and American Type Culture Collection among others.
January 2020 : Swiss food giant Nestle bulked up its medical nutrition business by purchasing Allergan’s (AGN.N) Zenpep, a product for people whose pancreases do not provide enough enzymes to properly digest fats, proteins and sugars.
September 2019. Smartfish AS has initiated a strategic collaboration with the global healthcare company B. Braun to secure a global launch of its medical nutrition product Remune. B. Braun will launch Remune in close to 20 countries during 2019 and 2020, followed by several other markets in Europe, Asia and South America.
The report analyses the global oncology nutrition market based on nutrition support, type of cancer and geography. The oncology nutrition market by nutrition support is classified into enteral and parenteral nutrition. By type of cancer, the market is bifurcated into head & neck cancer, gastrointestinal cancers, esophageal cancer, pancreatic cancer, liver cancer and blood cancer etc.
Key players in the global Oncology Nutrition market include Eurofins Scientific, Charles River Laboratories International, Becton, Dickinson and Company, SGS, Merck KGaA, bioMérieux , Pacific Biolabs , WuXi AppTec , North American Science Associates, and American Type Culture Collection among others.
Why to buy this report:
